ArticlePLOS mental health2026
Prevalence of significant depressive symptoms and associated factors among facially disfigured pediatric Noma patients in Nigeria: A single-centre cross-sectional study.
Article in PLOS mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Saving faces is not enough: Mental health must become core noma care.PLOS mental health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noma is a neglected tropical disease that causes severe facial disfigurement and significant morbidity, yet there is limited evidence regarding the psychological well-being of affected children. This study aimed to determine the prevalence of depressive symptoms and identify associated factors among pediatric Noma patients attending the Noma Children Hospital in Sokoto, Nigeria. A cross-sectional study was conducted involving 244 pediatric patients aged 6-16 years who had been facially disfigured by Noma and were undergoing rehabilitation or awaiting surgery. Data were collected using a structured questionnaire that included sociodemographic characteristics and the Center for Epidemiologic Studies Depression Scale (CES-D) to assess depressive symptoms. Binary logistic regression was performed to identify predictors of high depressive symptoms. Statistical significance was set at p < 0.05. The prevalence of clinically significant depressive symptoms among the participants was 76.6% (95% CI: 70.9-81.4%). Multivariate analysis revealed that gender, parental employment, and household income were associated with depressive symptoms. Female patients were significantly more likely to exhibit high depressive symptoms compared to males (OR = 3.251, 95% CI: 1.499-7.048, p = 0.003). Higher household income was associated with increased odds of depressive symptoms (OR = 3.411, 95% CI: 1.624-7.167, p = 0.001), whereas parental employment was significantly associated with reduced odds (OR = 0.401, 95% CI: 0.217-0.739, p = 0.003). There is a substantial burden of depressive symptoms among pediatric Noma patients in Nigeria, with female gender and family socioeconomic factors significantly shaping the risk. These findings highlight the critical need to integrate mental health screening and psychosocial interventions into Noma care protocols.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.